Biosimilars and interchangeable biosimilars: facts every prescriber, payor, and patient should know. Insulins perspective.
Sign Up to like & getrecommendations! Published in 2022 at "Expert opinion on biological therapy"
DOI: 10.1080/14712598.2022.2112664
Abstract: INTRODUCTION For many of the 537 million adults living now with diabetes, the cost of insulin is becoming prohibitive as the insulin prices have tripled between 2002-2013. Globally, the direct annual cost of healthcare expenditure… read more here.
Keywords: facts every; interchangeable biosimilars; biosimilars facts; biosimilar insulin ... See more keywords